Tradestie Institutional Equity Comparison Engine

BIAF vs FLZH โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BIAF Overall Edge

BIAF Captures Institutional Edge (2โ€“0 Pillars ยท 7โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to bioAffinity Technologies, Inc. Common Stock (BIAF) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, BIAF trades at N/M Forward P/E with -246.1% operating margin (-26.0% YoY revenue) versus FLZH at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, BIAF sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against FLZH sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
BIAF N/M vs FLZH N/M Fwd P/E
Growth & Margin Winner BIAF
Op Margin -246.1% vs N/A ยท YoY -26.0% vs N/A
Momentum & Technical Winner BIAF
1Y +12.2% vs -97.5% ยท 52W Pos 7% vs 0%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
BIAF NASDAQ
bioAffinity Technologies, Inc. Common Stock
Services-Commercial Physical & Biological Research
$1.65
-10.81% 1D
Market Cap $3.3M
1M Return -47.95%
1Y Return +12.24%
Forward P/E N/M
Unified AI Score
48.0 / 100 HOLD
Tech 38.0 Fund 51.0 Flow 50.0 Mom 64.0
FLZH US Equity
FLZH
Institutional Equity
$0.10
-56.54% 1D
Market Cap N/A
1M Return -92.93%
1Y Return -97.5%
Forward P/E N/M
Unified AI Score
48.8 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BIAF +12.24% FLZH -97.5% Spread: +546.82 pp (BIAF Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BIAF TTM Op. Margin: -246.1% FLZH TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BIAF vs FLZH. Trailing 12-month operating profitability (BIAF -246.1% vs FLZH N/A) and valuation multiples (BIAF N/M vs FLZH N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BIAF (7) vs FLZH (1)
Institutional Metric BIAF FLZH Criterion Row Winner
Market Capitalization Scale $3.3M N/A Larger Scale BIAF
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -26.0% N/A Higher Growth BIAF
Operating Margin (TTM) Profitability -246.1% N/A Higher Margin BIAF
Net Profit Margin Profitability -278.9% N/A Higher Margin BIAF
Return on Equity (ROE) Capital Efficiency -240.5% N/A Higher ROE BIAF
52-Week Range Position Momentum 7% ($0โ€“$20) 0% ($0โ€“$4) Stronger Trend BIAF
Beta / 30D Volatility Risk Regime -0.62ฮฒ ยท 120% Vol 3.90ฮฒ ยท 329% Vol Lower Realized Risk BIAF
Unified Institutional Score Composite Signal 48.0 / 100 (HOLD) 48.8 / 100 (HOLD) Higher Composite FLZH

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BIAF vs FLZH Buy Guide
BIAF UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BIAF Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
FLZH UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live FLZH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BIAF nor FLZH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.